SI-BONE with significant market potential for sacroiliac joint fusion - record revenue in Q4 could end bottom formation!
Reading Time: 2 minutes
The Silicon Valley company SI-BONE (SIBN) specializes in innovative medical technology for the treatment of musculoskeletal disorders and provides innovative minimally invasive implants for stabilizing the sacroiliac joint. The iFuse implant system is regarded as the only clinically tested minimally invasive fusion method as an alternative to open surgical procedures. The company aims to build a comprehensive medical device platform for orthopedists, neurosurgeons, trauma surgeons, and interventional spine doctors with sought-after product innovations...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
